Secondary Treatment of Acute Graft-versus-Host Disease: A Critical Review
Authors:
Open Access
- 1 July 2012
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (7) , 982-988
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA98906)
- Department of Health and Human Services
This publication has 76 references indexed in Scilit:
- Treatment of chronic graft-versus-host disease: Past, present and futureThe Korean Journal of Hematology, 2011
- Analysis of Clinical Outcome and Survival in Pediatric Patients Undergoing Extracorporeal Photopheresis for the Treatment of Steroid-refractory GVHDJournal of Pediatric Hematology/Oncology, 2010
- Rapamycin for Refractory Acute Graft-Versus-Host DiseaseTransplantation, 2009
- Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint StatementTransplantation and Cellular Therapy, 2009
- Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host DiseaseJournal of Pediatric Hematology/Oncology, 2009
- Therapy with mycophenolate mofetil for refractory acute and chronic GVHDBone Marrow Transplantation, 2009
- Extracorporeal photopheresis for the treatment of steroid refractory acute GVHDBone Marrow Transplantation, 2008
- Infliximab for GVHD therapy in childrenBone Marrow Transplantation, 2007
- How I treat refractory acute GVHDBlood, 2007
- Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2005